SEC Form 4 · accession 0001437749-17-006117
Vaxart, Inc. · VXRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph M Patti
Officer — CEO · Director
Period of report
Apr 3, 2017
Accepted (ET)
Apr 5, 2017 · 1:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000072444
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.656 | Apr 3, 2017 | A | 650,000 | A | Oct 3, 2017 | Apr 3, 2027 | Common Stock | 650,000 | 2,113,304 | D |
Explanation of responses
- F1This stock option vests as follows: 33% of the total stock option vests six (6) months after the grant date, on October 3, 2017 and the remainder of the stock option vests in equal monthly installments beginning November 3, 2017 to April 3, 2018.